Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients

(1) Background: Immune compromised hemodialysis patients are more likely to develop COVID-19 infections, which increase the risk of mortality. The benefits of Remdesivir, despite less literature support on its effectiveness in dialysis patients due to renal toxicity, can outweigh the risks if prescr...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Batool Butt, Tajamul Hussain, Mu’taman Jarrar, Kashaf Khalid, Waleed Albaker, Asma Ambreen, Yasir Waheed
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2022-01-01
Цуврал:	Antibiotics
Нөхцлүүд:	COVID-19 hemodialysis remdesivir ESRD
Онлайн хандалт:	https://www.mdpi.com/2079-6382/11/2/156
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!